sec filing
CS
NASDAQ · CSBR
Champions Oncology, Inc.
Healthcare · Biotechnology
$5.07
Down-$0.07 (-1.27%)
Updated Aug 15, 2026, 10:34 PM
SID Score
2.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 87.12M
- P/E ratio
- 29.81
- Dividend yield
- 0.00%
- 52-week range
- $4.88 – $7.00
- Volume
- 26.34K
- Avg. volume
- 19.79K
Price performance
CSBR price history
1M range · 21 trading sessions · Daily adjusted prices
CSBR closed at $5.07 after 21 trading sessions, down 17.37% for the selected period.
- Last close
- $5.07
- Period change
- -17.37%
- Period low
- $4.95
- Period high
- $6.13
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 14, 2026 | $5.02 | $5.37 | $4.94 | $5.065 | 26.34K |
| Aug 13, 2026 | $4.88 | $5.13 | $4.88 | $5.08 | 14.22K |
| Aug 12, 2026 | $4.89 | $5.09 | $4.89 | $4.95 | 5.68K |
| Aug 11, 2026 | $5.06 | $5.3892 | $4.88 | $4.99 | 16.14K |
| Aug 10, 2026 | $5.18 | $5.21 | $5.09 | $5.14 | 7.68K |
| Aug 7, 2026 | $5.00 | $5.27 | $5.00 | $5.19 | 4.79K |
| Aug 6, 2026 | $5.39 | $5.41 | $5.15 | $5.19 | 15.82K |
| Aug 5, 2026 | $5.37 | $5.40 | $5.20 | $5.30 | 14.57K |
| Aug 4, 2026 | $5.605 | $5.73 | $5.40 | $5.45 | 18.69K |
| Aug 3, 2026 | $5.26 | $5.76 | $5.26 | $5.76 | 2.93K |
| Jul 31, 2026 | $5.32 | $5.50 | $5.32 | $5.36 | 2.01K |
| Jul 30, 2026 | $5.30 | $5.4501 | $5.215 | $5.26 | 16.4K |
| Jul 29, 2026 | $5.3857 | $5.591 | $5.3857 | $5.46 | 11.56K |
| Jul 28, 2026 | $6.48 | $6.48 | $5.39 | $5.53 | 30.94K |
| Jul 27, 2026 | $6.10 | $6.15 | $6.06 | $6.06 | 8.29K |
| Jul 24, 2026 | $6.00 | $6.16 | $5.75 | $6.13 | 11.29K |
| Jul 23, 2026 | $5.71 | $6.00 | $5.71 | $6.00 | 1.41K |
| Jul 22, 2026 | $6.16 | $6.16 | $5.95 | $6.13 | 2.81K |
| Jul 21, 2026 | $6.10 | $6.13 | $6.10 | $6.10 | 977.7 |
| Jul 20, 2026 | $6.10 | $6.1499 | $6.10 | $6.10 | 2.13K |
| Jul 17, 2026 | $5.97 | $6.13 | $5.97 | $6.13 | 11.86K |
Latest CSBR news
The latest Smart Investors Daily articles mentioning CSBR.
Stock researchCompany · Financials
Loading stock research…